AXYCIS

Generic: CISPLATIN

AVYXA PharmaManufacturer
INTRAVENOUSRoute
CISPLATINActive Substance
2026-10-29Original Approval

AXYCIS is FDA application NDA220748, sponsored by AVYXA HOLDINGS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.